← Open Payments lookup

ARIEL ALMACEN: Open Payments

NPI 1033257241 · BELLEVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,664 in 52 payments from 10 companies in 2025. Trend: 2023 $559 · 2024 $645 · 2025 $1,664

Food & beverage: $1,553Education: $111
CompanyPaymentsAmount
Alkermes, Inc.19$541
Teva Pharmaceuticals USA, Inc.6$367
Janssen Pharmaceuticals, Inc12$271
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$127
ABBVIE INC.1$125
Otsuka America Pharmaceutical, Inc.6$113
E.R. Squibb & Sons, L.L.C.3$47
Neurocrine BioSciences, Inc.2$41
Lundbeck LLC1$18
Luye Pharma (USA) Ltd.1$15

Products named: LYBALVI, ARISTADA, UZEDY, INVEGA SUSTENNA, CAPLYTA, VRAYLAR, SPRAVATO, ABILIFY ASIMTUFII.

Industry payments across NJ — which companies pay providers there.